Dr. Jennifer Tippett is a licensed clinical psychologist and Director of Psychotherapeutic Development for Atai Life
Sciences, creating therapeutic protocols, and providing facilitator training for psychedelic clinical trials. She
previously held an academic appointment and served as the Director of the Substance Use Disorder Specialty
Program for the University of Denver’s Graduate School of Professional Psychology, training students in addiction and the neurobiology of trauma. Dr. Tippett’s early career focused on working with incarcerated populations as well as individuals struggling with severe and persistent mental illness, providing high-quality therapeutic services in limited and under-resourced systems. This work became a driver to explore innovative means of delivering mental health care, including psychedelic medicine. Dr. Tippett studied psychedelics through the lens of shamanistic/indigenous traditions as well as gaining formal certifications from Fluence, Polaris, MAPS, and Integrated Psychiatry Institute. She is also a level 1 Internal Family Systems provider and is dedicated to combining psychedelics and evidence-based therapy models. As the psychedelic field rapidly expands, Dr. Tippett continues to focus on removing barriers to cutting-edge and effective mental health interventions for those who need them most.